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ABSTRACT

The objective of this project was to develop a DNA hybridization sensor that can detect
the presence of E. coli and reveal its resistance to the drug gentamicin. This probe will enable rapid
and user-friendly diagnostics of E. coli infections and analysis of bacterial gentamicinsusceptibility profile by interrogation of a fragment of E. coli 16S rRNA bearing a substitution in
the gentamicin-resistant cells. The sensor is promising for the point-of-care use to provide a timely
UTI diagnostic solution. A quick diagnosis of E. coli infection and antibiotic resistance is crucial
for treatment. To design a hybridization probe, we proposed a split approach for target
interrogation and catalytic activity of a peroxidase-like deoxyribozyme (PDz) as a signal reporter.
PDz contains a series of guanine residues in a strand and has been shown to form a parallel
guanine-quadruplex (G4). This G4, with the addition of a hemin cofactor, catalyzes the reaction
similar to that of horseradish peroxidase. If a colorless organic indicator is added to the G4-PDzhemin containing solution and mixed H2O2, a colored oxidation product is formed (e.g., a dark
blue/green). The color change reports the presence of the catalytically active G4, which occurs
only when the nucleotide sequence of the target is a perfect match. When the target is not a perfect
match, for example, in the case of the drug-causing nucleotide substitution, the G4 does not form,
and there is no color change. The probes tested in this paper show promising results of such a
sensor by being able to catalyze the described colorimetric reaction to generate a strong signal in
the presence of a “gentamicin-susceptible” target and show selectivity against the “gentamicinresistant” target.
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INTRODUCTION
Urinary tract infections (UTI) are a universal health care issue. Escherichia coli (E. coli) is
the cause of 75-90% of urinary tract infections.1 Untreated UTIs can develop into diseases such as
pyelonephritis, which is when the bacteria spread from the bladder to the kidneys, causing more
severe symptoms, such as back/flank pain and vomiting.2 With around 400,000 cases of UTIs
leading to hospitalization each year, the total healthcare cost associated with UTI has been
estimated to be $3.5 billion annually in the United States.3-4 Timely diagnostics of UTI with more
precise treatment have the potential to reduce the number of victims and annual cost.

A conventional approach for UTI diagnostics, apart from the one based on symptoms, relies
on culturing the cells, which takes 24 hours or more for growth.5 This wait period for confirmation
delays treatment initiation; rapid treatment is crucial to prevent the development of symptoms and
halt the spread of the infection. Another limitation of current diagnostics is that these methods
have an error rate of about 33%.5 This means 1/3 of patients with a UTI may not be correctly
diagnosed the first time and, therefore, may go untreated, leading to other potential health issues.

The treatment and control over UTI are further complicated by the fact that E. coli develops
resistance to the antibiotics generally prescribed for bacterial UTI treatment. For example, one of
the most effective first-line antibiotics against UTI-causing bacteria, such as E. coli, is an
aminoglycoside antibiotic gentamicin. 6-7 The mechanism of gentamicin’s action involves binding
at helix 44 (A-site) of the 16S rRNA component of the 30S ribosomal subunit, thereby preventing
the correction of incorrectly bound aminoacyl-tRNA, which causes bacteria to synthesize proteins
1

with wrong primary structure.7-8 One of the mechanisms bacteria develop resistance to gentamicin
is through modification of the sequence of 16S rRNA by acquiring point-mutations in the rrs gene
encoding 16S rRNA.7-8 The substitution of guanine at the position nt1408 or adenine at nt1406 of
16S rRNA with guanine prevents interaction of the drug with the A-site of the bacterial ribosome
and the cell can grow unimpeded.6,10 This substitution that is tightly linked to gentamicin resistance
occurs in about 12.9% of E. coli cells.9

Differentiation between wild type (T1406) and mutant (T1406A) genotypes constitutes the
grounds for molecular gentamicin-susceptibility testing. Current methods analyzing the molecular
basis of antibiotic-resistant genes involve real-time Polymerase Chain Reaction (PCR).11 This
technique has limited validity due to the increased number of false positives, while having a run
time of about an hour and increasing the cost of running the test.11 RNA mutations can be detectable
using the enzyme Reverse-Transcriptase followed by rounds of PCR amplification in realtime.1 PCR techniques for discrimination between point mutations may require a melting
temperature profile at the end of the amplification. This melting temperature profile can only be
done with qPCR instruments, which not hospitals or private clinics have due to expense. PCR,
therefore, cannot be used to diagnose all bacteriuria as it would be inadequate when it comes to
showing presence of antibiotic-resistant bacteria or when there are no bacteria.11-12 The use of
a TaqMan probe for genotyping samples requires the use of Thermocyclers and thermo-stable
DNA polymerases, which are not readily available in clinic settings. Other techniques often utilize
probes following PCR, adding time to the point of complete diagnosis. The most ideal tool for
detection of mutations will be expedient, easy to use, and accurate, which is exactly how the
proposed method for detection will perform.
2

We proposed a method for molecular detection of the presence and antibiotic resistance
in E. coli that involves using a split hybridization DNA probe that exhibits enzymatic activity
capable of a colorimetric assay. Similar probes have been tested previously for the detection of
non-tuberculosis mycobacteria, zika virus, rifampin resistant mycobacterium tuberculosis and
others.13-15 It has been demonstrated that the probes are very sensitive to single nucleotide
substitutions.13-17 Using this probe, the presence of an RNA target can be detected within 30 minutes
or less at room temperature without the need of expensive instrumentation to monitor the signal,
since the probe results in the color change of a solution in response to a specific target. Such
instrument-free visualization makes it easy to read the test results, and for those reasons deliver
the most optimal treatment to patients.

To design a hybridization probe, we used a split approach for target interrogation and
catalytic activity of a peroxidase-like deoxyribozyme (PDz) as a signal reporter. The “Split”
approach uses two probes each with G4 forming arms and each with analyte-binding arms that are
complementary to a target. Upon hybridization of the analyte-binding arms to the target, the G4
forming arms are coordinated together to fold into the G4 (Figure 1). PDz contains a series of
guanine residues in a strand and has been shown to form a parallel guanine-quadruplex (G4). This
G4, with the addition of a hemin cofactor, has been found to catalyze the reaction similar to that
of horseradish peroxidase.16 If a colorless organic indicator (e.g., ABTS2-) is added to the G4-PDzhemin containing solution and mixed hydrogen peroxide, a colored oxidation product is formed
(e.g., a dark blue/green ABTS-.). The color change reports the presence of the catalytically active
G4 (Figure 2).
3

Figure 1: Design and mechanism of action of a colorimetric split PDz probe (sPDz).17

Figure 2: Mechanism of G4-PDz-hemin catalysis of a peroxidation reaction.18
The catalytic cycle of ABTS peroxidation by the G4-PDz-hemin complex is depicted in Figure 2. The reduced
form of hemin (top left) can reduce H2O2 into H2O to generate Compound I. Compound I will now oxidize
ABTS2- (colorless) into the colored product ABTS.-, which will generate Compound II. Compound II is capable of
catalyzing another oxidation round to convert another molecule of ABTS2- into ABTS.-, which will regenerate the
catalyst hemin, thereby producing two molecules of colored product per cycle of catalysis.18 The increase in oxidized
ABTS- molecules is positively correlated with absorbance of the solution. The reaction has the most significant
absorbance values within 15 minutes of incubation and can be measured at 420 nm (absorbance of ABTS .-) on a
spectrophotometer.
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OBJECTIVE

The objective of this project is to develop and test a DNA hybridization probe that can
detect the presence of E. coli and reveal its resistance to the drug gentamicin. This probe will
enable rapid and user-friendly diagnostics of E. coli infections and analysis of bacterial
gentamicin-susceptibility profile by interrogation of a fragment of E. coli 16S rRNA bearing an
T1406A substitution in the gentamicin-resistant cells. The probe is promising for the point-of-care
use to provide a timely UTI diagnostic solution. A quick diagnosis of E. coli infection and
antibiotic resistance is crucial for quintessential treatment.

5

METHODOLOGY

Materials:

The DNA oligonucleotides were obtained from IDT Inc. (Coralville, IA, USA) and
were not purified. The oligonucleotides were diluted with DNase free water to reach a final
concentration of 100 µM stock solutions. H2O2 and ABTS were obtained from Sigma-Aldrich (St.
Louis, MO, USA).

Procedures:

Colorimetric assay. Samples were prepared by mixing of the WT-S1 strand (1 µM), the
WT-U1 (1 µM) with or without Blocking Element (1 µM) in a colorimetric buffer containing 50
mM HEPES-NaOH, pH 7.4, 50 mM MgCl2, 20 mM KCl, 120 mM NaCl, 1% DMSO, and 0.03%
Triton X-100 at 22oC. To some samples, the targets (1 µM), either the wild type or containing a
point mutation at nt1406, were added. For color generation, hemin (0.375 M), ABTS2- (1 mM)
and H2O2 (1 mM) were added and incubated for 15 minutes to observe the change of the sample
solutions into a dark blue-green color. To optimize the assay conditions, the colorimetric buffer
was prepared at a pH of 6.8. In some experiments, the probe strands were annealed to the target
by heating at 95 ºC for three minutes and slowly cooling to room temperature overnight prior to
addition of hemin, ABTS2-, and H2O2. The color intensity was measured using a Thermo Scientific
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NanoDrop OneC UV-Vis Spectrophotometer (Waltham, MA, USA) at 420 nm. Tube images were
captured using a cell phone camera immediately before measuring the samples’ absorbance.

Extraction of total bacterial RNA.

E. coli cells were inoculated with a standard loop grown in two sets of 20 ml Luria-Bertani
(LB) media for 24 hours at 37oC in an attempt to keep the cells in the logarithmic growth phase.
Following the incubation, the two sets were combined and pelleted by centrifugation at 16,000 rcf
for 10 minutes at 4oC. The supernatant was decanted, and the remaining cells were gently
resuspended in 700 µL of nuclease free H2O and 1 mg of lysozyme for 10 minutes. The solution
was equally divided into two microcentrifuge tubes at 350 µL and an equal volume of PhenolChloroform was added in both and swirled. These microcentrifuge tubes were centrifuged at
16,000 rcf for 2 minutes at 4oC and two distinct layers were formed: the aqueous layer and the
organic layer. Because of the aromaticity of ribonucleic bases, the RNA was expected to separate
into the organic layer, where proteins and other cellular components were more likely to be
separated into the aqueous layer. The organic layer of each microcentrifuge tube was pipetted into
a fresh microcentrifuge tube without disturbing the aqueous layer. Next, the samples were
precipitated by adding 35 µL of 3 M sodium acetate, 1,000 µL of 100% ethanol, and 5 µL of
glycogen 1 mg/ml to both samples and then stored at -70oC for 10 minutes. Next, the samples were
centrifuged at 16,000 rcf for 2 minutes at 4oC to form a pellet and the supernatant was decanted.
500 µL of 70% ethanol was added to both samples and centrifuged once more at 16,000 rcf for 2
minutes at 4oC. The steps were repeated by decanting the supernatant, adding 500 µL of 70%
ethanol, and centrifuging once more and the supernatant was drained. The resultant precipitate was
7

resuspended in 20 µL of TE buffer at a pH of 8.1 each and the samples were labeled E. coli RNA
1 and 2 respectively. Next, an agarose gel was run to confirm the presence of the 16S ribosomal
RNA and to calculate the concentration in the TE buffer.

The 0.8% agarose gel was prepared by suspending 0.4 g of agarose in 50 mL solution of
1X TAE buffer followed by boiling the suspension until the suspension is homogenous, and no
agarose powder particles are visible. Once the solution cooled to 50oC, 5 µL of 10,000X GelRed
was added and swirled. Once mixed, the solution was poured into a horizontal casting tray with a
6-lane comb where the solution cooled into an agarose gel. 1X TAE buffer was poured over the
container until the gel was covered. Solutions were prepared with 1.5 µL of nuclease free H2O, 3
µL of 2X RNA Gel loading dye, and 1.5 µL of sample. Lane 1 contained the RiboRuler HighRange RNA Ladder as the sample, lane 2 and 3 each contained RNA from the samples suspended
into the TE buffer. The negative terminal was plugged into the bottom of the gel and the positive
terminal at the top. The machine was set to 80 V and run until the dye ran roughly two-thirds of
the way down, and then taken to the GelDoc for visualization.

This sample was then precipitated by adding 3.5 µL of 3 M sodium acetate, 110 µL of
100% ethanol, and 5 µL of glycogen 1 mg/ml to both samples and then stored at -70oC for 10
minutes. Next, the samples were centrifuged at 16,000 rcf for 2 minutes at 4oC to form a pellet and
the supernatant was decanted. 50 µL of 70% ethanol was added to both samples and centrifuged
once more at 16,000 rcf for 2 minutes at 4oC. The steps were repeated by decanting the supernatant,
adding 50 µL of 70% ethanol, and centrifuging once more and the supernatant was drained. The
reaction buffer was then prepared on top of this precipitate at 10 µL.
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RESULTS

Design of the Split G4-PDz Probes Targeting E. coli 16S rRNA

In order to make the signal to be dependent on the presence of a nucleic acid target, the
series of guanine nucleotides forming a G4 structure have been split between two strands of DNA
to make a split PDz (sPDz) probe.16 The sPDz probe has two strands, each strand containing a half
of the G4-forming nucleotides, and a target-binding arm. One strand has a long “unwinding”
target-binding arm that is complementary to both the wild type and mutant target; the second strand
has a short “selective” segment that is complementary only to the wild type target (in the case of
wild-type specific probes). The G4 structure is formed upon hybridization of the strands to the
complementary target, and the G4 can bind to hemin for the peroxidase reaction (Figure 1). The
probe was designed using the split-G4 approach because of the high selectivity that allows for
differentiation between the wild-type 16S rRNA sequence and the sequence containing singlenucleotide substitutions conferring drug-resistance. Mutations in the fragment of the target that
binds to the selective probe significantly reduces its ability to bind.13-17 Therefore, the wild type
target triggers a stronger signal, which can be clearly differentiated from the weak or no signal
caused by the mutant analyte. This selectivity can help aid in diagnosis and treatment more specific
to the strain of bacteria present.

We used a split G4 as a probe to interrogate a fragment of E. coli 16S rRNA, and also to
differentiate between the wild type RNA sequence (gentamicin-susceptible phenotype) and mutant
sequences with point mutations at nucleotide 1406 of the 16S rRNA, which has been correlated
9

with gentamicin resistance in E. coli.9-10 In the design of a split peroxidase-like deoxyribozyme
(sPDz) probe, strand U binds to the RNA target adjacent to strand S, which binds to the analyte
containing the locations 1406 of the wild type (WT) sequence. When the mutation is present, the
strength of the binding of the S strand is weaker because there are fewer complementary bases and
the G4 reporter is not formed, ensuring the selectivity for the technique. The blocking strand,
Strand B, binds upstream of the selective arm on the target. Because the blocking strand is so
complementary to the target it helps undo the secondary structure of the 16S ribosomal, thereby
increasing access for the hybridization of our probes to the target sequences. We also designed a
sPDz probe specific for the mutant 16S rRNA sequence. Due to the split character of the probe,
we only needed to adjust the sequence of strand S of the mutant-specific sPDz to be complementary
to the mutation-containing fragment of 16S rRNA. By using both WT- and mutant-specific probes,
it was possible to answer two questions at the same time: (1) whether or not E. coli has been
accumulated in the biofluid samples; and (2) whether or not the bacterial species are susceptible
to gentamicin. Alternatively, another probe that interrogates the sequence of E. coli 16S rRNA
outside the fragment containing the mutation position (or 23S rRNA) can be used in combination
with either WT or mutant-specific sPDz to provide the answer to these two questions. The
sequences for the strands of sPDz probes are listed in Table 1.

In order to test and optimize the performance of the designed sPDz probes, synthetic 89-nt
DNA sequences that correspond to the targeted fragment of 16S rRNA from E. coli were used as
analytes. The sequences of the synthetic analytes are shown in Table 1. We expected that the WTspecific probe would bind to the WT analyte very well, but presence of T1406A substitution in the
analyte would prevent the probes from binding, and therefore there would be no PDz formed to
10

catalyze the peroxidase reaction, as illustrated in Figure 1, left, so little to no colored product would
form. The structure of the complex between the probe and WT analyte without the blocking strand
is shown in Figure 3. The structure with the addition of the Blocking Element is shown in Figure
4 and the free energy of the complex is estimated to be -499.82 kJ/mol, which means this structure
is very favorable. Nupack was used to calculate the structure and stability under the proposed
conditions, but the tool is not capable of creating the G-quadruplex (https://www.nupack.org).19
However, the G-quadruplex forming arms are visibly coordinated by complexing to the analyte.

Table 1: The sequences of the sPDz probe strands and analytes used in the project. a

Sequence (5’→3’)
GTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGGGAGTGGGT
TGCAAAAGAAGTAGGTAGCTTAACCTTCGGGAGG
T1406A GTGAATACGTTCCCGGGCCTTGTACACACCGCCCGACACACCATGGGAGTGGGT
TGCAAAAGAAGTAGGTAGCTTAACCTTCGGGAGG
Blocking GTGTACAAGGCCCGGGAACGTATTCACC
Element
WT-S1 GGGTTGGGTGTGTGACG
WT-U1 GCTACCTACTTCTTTTGCAACCCACTCCCATGTGGGTTGGG
WT-S2 GGGTTGGGTGTGTGACG
WT-U2 CTACCTACTTCTTTTGCAACCCACTCCCATGTGGGTTGGG
WT-S3 GGGTTGGGTTGTGACGGG
WT-U3 CTACCTACTTCTTTTGCAACCCACTCCCATGGTGGGTTGGG
WTGGGTTGGGTGTGTGACGGCCA
slD2SA-1
WT-slS2 GGGTTGGGTGTGTGACGGACC
WT-slS3 GGGTTGGGTTGTGACGGGCACC
Name
WT

a

WT is the 89-nucleotide long analyte to represent the 16S rRNA. The abbreviation “S” represents the selective arm,

with a short binding sequence that has a temperature of melting (Tm) of 26 oC. “U” is the unwinding arm that has a
30-nucleotide analyte-binding arm. T1406A represents the mutant allele on the target, which was used to show the
probes can clearly differentiate the wild type from no target present. A stem-loop constraint was added to some of the
designs in order to increase selectivity, the designs with this addition are labeled with the letters “sl” and have bolded
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and italicized residues to show which sequences form the stem-loop. (Note: Color coordination represents
corresponding complementary sequences, expected to anneal. Underlined residues represent single nucleotide
substitutions.)

Figure 3: Structure of the complex formed by the sPDz probe with the WT target in the absence of the Blocking
Element.
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Figure 4: Structure of the complex formed by the sPDz probe with the WT target.

We optimized the following parameters of the sPDz probe: the signal; the selectivity. The
signal was measured by the absorbance at 420 nm, subtracted by the background absorbance. The
selectivity is the quantitative measure of the difference between the absorbance from the wild type
and the absorbance of the mutant. When designed properly, the wild type has high amounts of
catalyzation, while the mutant does not. We tested the selectivity of the probe using WT and mutant
analytes. The selectivity was measured using the selectivity factor (SF) calculated with Equation
1.
SF = 100% * (1 – (AM-A0)/(AWT-A0))
Equation 1: Selectivity Factor

AM is the average absorbance of the probe triggered by the mismatched target, A0 is the
average absorbance of the No-Target-Control, AWT is the average absorbance of the probe triggered
13

by the specific target. The probes were only considered effective when the selectivity was greater
than 80% but are best when greater than 95%. For example, if the signal triggered by the fully
complementary target is low, the analyte-binding arm of strand S can be extended, giving it more
complementary regions for binding. Another tool to increase the signal was to introduce a nonnucleotide linker between the G4-forming and analyte-binding fragments of the strands for
improved flexibility.17 If the selectivity is not optimal, the length of the analyte-binding arm of
strand S can be reduced, which would decrease the melting temperature of the probe’s complex
with the mutant analyte. Alternatively, a structural constraint in the form of a stem-loop could be
introduced in strand S, as described in Connelly 2019. In this case, a segment on the selective arm
can be added that is complementary to a portion of the G4-forming fragment. When introduced
into the solution it has to balance between intermolecular (probe binding to the analyte) and
intramolecular (probe binding to itself) forces, which will skew the equilibrium, making it so fewer
G4 will form when the binding arm is weaker, such as with mutations. The self-complementary
loop should not decrease the signal of the wild type significantly, but it significantly increases the
selectivity for these conditions.17

The sensors were first tested in the absence of Blocking element. This element was
designed and added into the experiment to serve the function of making the region of interest more
open to the split-G4 probes. The Blocking element has the capabilities of binding with a strong
affinity to a region downstream of the mutation site. This affinity was hypothesized to undo the
secondary structure of the 16S rRNA to increase the ability of the probes to access the target. A
sample was tested under annealing conditions to find the ability of the probe to catalyze the
reaction when bound to the target. The annealing conditions have been previously shown to
14

increase the signal by raising the temperature of the solutions to at 95ºC for five minutes and letting
the probes hybridize, forming the most stable conformation.

Figure 5: Absorbance at 420 nm without Blocking Element
(Normal conditions on left; Anneal on right.) ⌀ is the blank control sample, only containing the buffer solution and
added reagents. NTC is the no target control sample, which contains the buffer, the WT-S1 and WT-U1 probe strands
and the added reagents. WT sample contains all the components, the buffer, synthetic probes, WT target, and the
added reagents. The three samples on the left were performed without prior annealing of the probe strands to the target.
The three samples on the right were performed under annealing conditions. Three trials of each experiment were
performed unless no error bars are shown in the figure. The error bars represent the standard deviation of the three
trials.

The no-target control (NTC) sample contained WT-S1 and WT-U1 in the absence of the
Blocking element and any target in the reaction buffer. The WT condition had the WT target, the
WT-S1 and WT-U1, but no Blocking Element. As can be seen from Figure 5, the WT sample
15

could not be differentiated from the NTC sample without annealing of the probe to the target (left
panel). However, with the annealing step, the probes were able to bind to their specific target to
form the PDz core to catalyze the reaction and produce a dark-colored product (right panel). This
shows that when the probes bind, they can catalyze the desired reaction, but they need help binding
to the target.

The samples were not capable of generating a strong enough signal without the Blocking
element and/or prior annealing to the target. This is most likely due to the fact that the target has a
high secondary structure with itself, preventing hybridization of the probes to the target. Because
the samples were not able to give a high signal, a new method needed to be added to help the
sensors bind but keep selectivity with the WT and the mutants. The design must have a high affinity
to the target to shift the equilibrium and open up the target strands for binding. The Blocking
element was designed to accomplish such a task and was added to the next sets to test its ability to
do so.

Effect of a Blocking Element

The next sets were prepared in the same methods previously described, but with the addition of
the Blocking Element.
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Figure 6: Absorbance at 420 nm of Sets with WT-S1 and WT-U1 without prior annealing (Left) and Anneal (Right)
following incubation with reagents.
The “_B” denotation represents the samples that were made in the presence of the Blocking Element. The three
samples on the left were measured without prior annealing of the probe strands to the target. The three samples on the
right were performed under annealing conditions. The WT Control samples contained the solution with only the
reagents and the WT target, but no probes to bind to. This control group was used to ensure the WT target was not
catalyzing the reaction on its own.

The results of the assay testing in the presence of the Blocking element without probetarget annealing show the success of the probe to give off signal when binding to the targets (Figure
6, left panel). For these initial samples, a control group called “WT control” was added to ensure
that the WT DNA strands by themselves were not catalyzing the reaction. These samples were
prepared in the same manner as the negative controls with the addition of 1 M of the WT target
strands alone. Due to the high number of guanine nucleotides in the WT sequence, this test was
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performed to confirm that the WT DNA by itself is incapable of forming the G4 and would not
catalyze the reaction and invalidate the results. The next sample, labeled WT, was used to measure
the ability of the synthetic probes to bind to the WT DNA and catalyze the reaction. The WT
sample was prepared the same as the blank control, but with the addition of WT target DNA and
the WT-S1 and WT-U1 probes. When comparing the WT sample from Figure 6 to the controls,
you can see a differentiation between the two samples. The comparison of the WT with and without
the blocking element shows that by adding the blocking element to this solution, the signal
increases (compare left panels in Figures 5 and 6).

The annealed set was prepared in the same solutions as the previous set, but under
annealing conditions. The WT condition had the WT-S1 and WT-U1 probes and target DNA, so
the annealing conditions increased the hybridization of these two entities, resulting in a greater
amount of reaction catalyzed and a greater absorbance.

The next set, the incubated set, was also prepared in the same solutions as the normal
conditions, but the DNA samples were allowed to incubate together for a minimum of 24 hours at
room temperature before adding the reagents and measuring the samples after 15 minutes. This
period of 24 hours for incubation was to allow more time for the DNA samples to reach equilibrium
of their annealed states.
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Figure 7: Absorbance at 420 nm of sets following 24 hours of incubation.
⌀ is the blank control sample, only contained the buffer solution and added reagents. NTC is the no target control
sample, which contains the buffer, the WT-S1 and WT-U1 probes and the added reagents. The WT Control samples
contained the solution with only the reagents and the WT target, but no probes to bind to. This control group was used
to ensure the WT target was not catalyzing the reaction on its own. WT sample contains all the components, the buffer,
synthetic probes, WT target, and the added reagents.

By observing Figure 7, the WT sample had a strong change in color compared to their
respective controls. The conditions of these samples would not be ideal for clinical settings as the
results take much longer than the proposed test. This set was merely designed to measure the ability
of the probes to bind to the target, and it showed they can bind very strongly.

The last set shown below was done under identical conditions as the normal set, except that
the pH of the solution had been changed to a pH of 6.8 from 7.4 (Figure 8). This change in pH was
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expected to increase the absorbance for all samples including the NTC sample. By observing
Figure 8 and comparing those samples to the samples shown in the left panel of Figure 6 (No
annealing), the color change is prominent.

Figure 8: Absorbance at 420 nm of WT-S1 and WT-U1 sets at pH 6.8 following incubation with reagents.
The WT_B sample contained the WT target, Blocking element, the WT-S1 and WT-U1 probes. The WT Control
samples contained the solution with only the reagents and the WT target, but no probes to bind to. This control group
was used to ensure the WT target was not catalyzing the reaction on its own.

Upon analyzing the all of the above results and further consideration of the WT-S1
selective arm, we concluded that this design will not be selective enough when it comes to the
A1408G mutant vs. wild type testing. The 1408 mutation site will be too close to the junction of
the G4, so the substitutions could form Wobble base pairs and decrease selectivity. One of the
future goals of this project is to test this probe on the A1408G mutation, which lead to the decision
that a readjustment was necessary. The subsequent probes were designed by shifting the selective
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arm up a small number of nucleotides. The redesigned probes were then tested in similar conditions
to learn about the new designs’ ability to bind and catalyze the reaction, and the strength of the
reaction.

Selectivity of the G4-PDz Probes

The new WT-S2 and WT-U2 probes with an upward shift were tested first, with and
without the Blocking Element to learn about its effect on the signal produced. Additionally, a DNA
target containing the T1406A mutation, such as the mutation in the 16S ribosomal subunit that is
associated with gentamicin resistance was tested. This target will be compared to the signal of the
wild type target to analyze the probe’s selectivity.

Figure 9: Absorbance at 420 nm of WT-S2 and WT-U2 without Blocking Element (Left) and with Blocking Element
(Right) sets following incubation with reagents.
T1406A is the mutant sequence tested that is correlated with gentamicin resistance.
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The WT-S2 and WT-U2 samples showed no change in signal in the presence of the
Blocking Element compared to the counterparts without the Blocking Element. These samples also
experienced a slightly higher background signal than some previous designs, but it remained at a
moderate and workable level.

Figure 10: Absorbance at 420 nm of WT-S3 and WT-U3 without Blocking Element (Left) and with Blocking Element
(Right) sets following incubation with reagents.

The samples containing the WT-S3 and WT-U3 with and without the Blocking Elements
had a high background signal. This can most likely be explained by the samples forming the G4
without being coordinated by binding to a target. The signal was also increased when binding to
the T1406A target when compared to the WT, which was the opposite of the intended design.

It was decided that the effect of the blocking element would vary in a case-by-case scenario
and that all of the designs would be tested with or without the presence of a blocking element.
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The probes with high signal and low background will be the most promising to optimize.
Since selectivity can be increased by adding constraints, such as stem-loops, such designs will be
added following choosing the most optimal sensors. Because of the low WT to background signal
ratio, the S3/U3 designs most likely would not be able to be optimized for the purposes of this
experiment. The S1/U1 pair was predicted to be unsuccessful distinguishing mismatches because
of the high chance of having wobble base pairs to the substitution. The S2/U2 designs appeared to
be the most promising to optimize to the purposes of this experiment. Both the second and third
designs, WT-S2/U2 and WT-S3/U3, were modified to contain the addition of a stem-loop
constraint intended to increase the selectivity and decrease the background signals.

Figure 11: Absorbance at 420 nm of WT-slS2 and WT-U2 without Blocking Element (Left) and with Blocking
Element (Right).
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Figure 12: Absorbance at 420 nm of WT-slD2SA-1 and WT-U2 without Blocking Element (Left) and with Blocking
Element (Right).

Figure 13: Absorbance at 420 nm of WT-slS3 and WT-U3 without Blocking Element (Left) and with Blocking
Element (Right).

The incubation test that allows the probes and target incubate for 24 hours is a great test to
understand a probe’s potential to produce a signal and be selective. This is because they are given
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plenty of time to reach equilibrium before the reagents are added, and this allows the sPDz to be
coordinated if it is favorable. The slD2SA-1 and U2 probes were run after 24 hours of incubation
with the targets and Blocking Element to see the signal and selectivity once the contents have
reached the most stable conformations (Figure 14).

Figure 14: Absorbance at 420 nm for slD2SA-1 probes after 24 hours of incubation at room temperature.

After analyzing the results of the incubation test (Figure 14), and the selectivity of all the
probes (Figure 9-13), it was decided that the slD2SA-1 probe in the presence of the Blocking
Element was the most promising. It offered the highest signal, with very low background activity,
and was selective for the WT target because a small signal was observed in the T1406A target.
The Blocking Element appeared to hurt the signal of the probe on the WT target, but it also had a
positive effect on the selectivity of this probe. The purpose of the Blocking Element was to
improve the probe on the 16S rRNA target, so this probe was then tested on an RNA target in the
presence of the Blocking Element, isolated from E. coli cells harvested in the lab for preliminary
data. This target will be tested without the presence of the Blocking Element in future projects.
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Interrogation of Total E. coli RNA
Following the methods described in the procedures section, the purified E. coli RNA was
run in an agarose gel electrophoresis to look for isolation of 16S rRNA. Two samples were
obtained from the phenol-chloroform RNA extraction and therefore both samples were run in the
gel (Figure 15). The E. coli 16S rRNA is 1541 nucleotides long, so we expected to see a band
approximately at the same level as the 1500 marker on the ladder. However, we ended up seeing
a slight smear that began at that height and ran down until about 200 nucleotides. The reason for
this smear was hypothesized to be the partial hydrolysis of the 16S rRNA. Due to time constraints
surrounding COVID-19 and social distancing regulations, the colorimetric assay was performed,
despite the apparent hydrolysis of the 16S rRNA WT E. coli target.

Figure 15: Analysis of samples of total E. coli RNA by 0.8% agarose gel electrophoresis. L – high-range RNA ladder
(size of the RNA markers are indicated next to the corresponding bands). Lanes 1 and 2 contain two different
preparations of total RNA isolated from E. coli cells.

The concentration was first calculated on the GelDoc by measuring the intensity of the
band in the sample lanes and comparing them to that of the RiboRuler High-Range RNA Ladder.
It was estimated that there was 6,234.2 ng of 16S rRNA in the 18.5 µL sample. If all 6,234.2 ng
26

of 16S rRNA precipitated then the target was at a concentration of roughly 1.19 µM; however, it
is unknown how much of the 16S rRNA was lost.

Figure 16: WT E. coli 16S rRNA Target with slD2SA-1 and U2 Probes.

Only one trial was performed with the 16S rRNA E. coli target in the presence of the
slD2SA-1 probe, however this trial showed promising results. The probes were still able to bind
to the target and generate a signal, despite the complex structure of the WT target. The probes were
not tested in the presence of a mutant 16S rRNA target because of the resistance to gentamicin,
but there is no reason to believe the probes would generate more signal on this target than on the
T1406A mutant DNA target, which would grant the probe enough selectivity to be ideal in clinical
settings.
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DISCUSSION

Currently, this publication outlines the use of targeting gentamicin resistance from
mutations in nt 1406 of the 16S rRNA in E. coli cells and their presence in the solution for optimal
diagnostics. Gentamicin resistance is also linked to mutations in the 1408 nucleotide of the 16S
rRNA in E. coli.7 Future plans of this laboratory are to test the probes on the A1408G mutation on
synthetic targets as well as the WT E. coli 16S rRNA without the presence of the Blocking element.
Other future plans are to develop similar mechanisms for detection of point mutations conferring
other kinds of antibiotic resistance in bacteria to be used quickly, easily, and efficiently to make
for enhanced clinical diagnosis and treatment. Another future goal is to develop a mutant-specific
probe, which can bind to the mutant targets to generate a signal, and when used in parallel with
the WT specific probes can distinguish between the presence and absence of E. coli, necessary for
UTI diagnostics. A final goal for this project would be to test the final probes on gentamicin
resistant E. coli to confirm the selectivity of the probes on live cells, not just synthetic targets.

Following further trials of the split-G4 probes on E. coli total RNA (Figure 16), the probes
should be tested on varying concentrations of E. coli RNA to validate the probes’ signal. By
varying the concentrations of E. coli RNA, we will show how dilute the samples can be and still
be useful for diagnosis.

Following the successful testing of the probes on E. coli RNA, the probes should be tested
using artificial urine spiked with E. coli cells. The artificial urine sample would contain
compounds that are commonly found in urine, such as urea, potassium, etc.20 A bacteriological
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filter could be used to filter the urine, which has a diameter between 0.5-5 µm. Using such a filter,
or centrifuge to create a pellet, can isolate the E. coli cells, thereby increasing the concentration of
rRNA in the solution we were targeting to run the reaction. The signal and selectivity could then
be calculated and analyzed for significance. RNA purification can be a long and tedious process,
which ideally should be bypassed to optimize expedient results. In order to show you can skip
having to purify total cellular RNA for diagnostics, the probes should be tested on E. coli lysates
after performing serial dilutions. However, it may not be optimal to use lysates because of the
presence of nucleases, which would break down the targets or probes, peroxidases, which would
indicate false positives, and other cellular components.

The presence of the Blocking Element had no significant changes on formation of the G4
compared to the samples that did not have this element. Additionally, it was thought that when the
stem-loop constraints are designed that in some cases the blocking element would block the
selective arm from binding. This would happen if the stem-loop portion hybridized somewhere
downstream without the presence of the blocking element, which would stabilize the structure. In
the presence of the blocking element, it may prevent that binding and the selective arm will be less
likely to bind. In other cases, the blocking element may help under the secondary structures of the
target, to make it easier for the binding arms of the G4 to bind. In some of the cases, the Blocking
Element hurt the signal or the selectivity factor, in other cases these values were positively
affected, and in some cases, there was no significant affect. Due to this variability, we suggest that
all samples and probes be tested with and without the presence of the Blocking Element to find
the most optimal conditions.
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